See more : Tantia Constructions Limited (TANTIACONS.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Arabian International Healthcare Holding Company (9530.SR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Arabian International Healthcare Holding Company, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- GX Acquisition Corp. II (GXII) Income Statement Analysis – Financial Results
- CPS Technologies Corporation (CPSH) Income Statement Analysis – Financial Results
- Freeline Therapeutics Holdings plc (FRLN) Income Statement Analysis – Financial Results
- Wag! Group Co. (PETWW) Income Statement Analysis – Financial Results
- Orient Cement Limited (ORIENTCEM.NS) Income Statement Analysis – Financial Results
Arabian International Healthcare Holding Company (9530.SR)
About Arabian International Healthcare Holding Company
Arabian International Healthcare Holding Company supplies healthcare equipment and solutions in the Kingdom of Saudi Arabia. The company engages in the retail and wholesale trade of medical and surgical equipment and tools, artificial - handicapped systems, surgical operation's accessories, hospital supplies, medical systems and programs, lab chemical analysis systems, and testing and scientific measurement systems. It also maintains medical and analytical lab systems and equipment. Arabian International Healthcare Holding Company was founded in 1973 and is based in Riyadh, Saudi Arabia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 806.92M | 642.70M | 618.54M | 818.69M | 697.03M |
| Cost of Revenue | 616.89M | 488.50M | 475.02M | 620.31M | 525.69M |
| Gross Profit | 190.04M | 154.20M | 143.52M | 198.38M | 171.34M |
| Gross Profit Ratio | 23.55% | 23.99% | 23.20% | 24.23% | 24.58% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 18.15M | 12.67M | 9.55M | 9.92M | 8.92M |
| Selling & Marketing | 19.24M | 14.64M | 9.41M | 10.24M | 9.25M |
| SG&A | 37.39M | 109.10M | 18.96M | 20.16M | 18.17M |
| Other Expenses | 112.58M | 2.83M | 72.00M | 79.90M | 72.30M |
| Operating Expenses | 149.97M | 109.10M | 90.96M | 100.06M | 90.47M |
| Cost & Expenses | 766.86M | 597.60M | 565.98M | 720.37M | 616.16M |
| Interest Income | 5.10M | 715.06K | 13.00M | 22.16M | 25.62M |
| Interest Expense | 39.86M | 18.51M | 13.00M | 22.05M | 25.62M |
| Depreciation & Amortization | 15.28M | 10.00M | 7.23M | 7.53M | 7.89M |
| EBITDA | 111.11M | 65.11M | 106.45M | 147.65M | 90.24M |
| EBITDA Ratio | 13.77% | 10.54% | 13.23% | 14.38% | 16.64% |
| Operating Income | 40.07M | 45.10M | 74.57M | 110.22M | 82.35M |
| Operating Income Ratio | 4.97% | 7.02% | 12.06% | 13.46% | 11.81% |
| Total Other Income/Expenses | 13.85M | -23.97M | -13.37M | -22.72M | -25.62M |
| Income Before Tax | 53.92M | 34.50M | 93.74M | 119.79M | 56.73M |
| Income Before Tax Ratio | 6.68% | 5.37% | 15.15% | 14.63% | 8.14% |
| Income Tax Expense | 11.57M | 10.90M | 11.42M | 24.00M | 15.60M |
| Net Income | 38.09M | 20.47M | 82.31M | 95.79M | 41.13M |
| Net Income Ratio | 4.72% | 3.19% | 13.31% | 11.70% | 5.90% |
| EPS | 1.92 | 1.29 | 4.12 | 4.79 | 2.06 |
| EPS Diluted | 1.92 | 1.02 | 4.12 | 4.79 | 2.06 |
| Weighted Avg Shares Out | 19.79M | 19.98M | 20.00M | 20.00M | 20.00M |
| Weighted Avg Shares Out (Dil) | 19.79M | 19.98M | 20.00M | 20.00M | 20.00M |
Source: https://incomestatements.info
Category: Stock Reports